NO20072764L - Kromanderivater som er nyttige syrepumpeantagonister - Google Patents

Kromanderivater som er nyttige syrepumpeantagonister

Info

Publication number
NO20072764L
NO20072764L NO20072764A NO20072764A NO20072764L NO 20072764 L NO20072764 L NO 20072764L NO 20072764 A NO20072764 A NO 20072764A NO 20072764 A NO20072764 A NO 20072764A NO 20072764 L NO20072764 L NO 20072764L
Authority
NO
Norway
Prior art keywords
compounds
disease
acid pump
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
NO20072764A
Other languages
English (en)
Inventor
Madoka Jinno
Hirohisa Shimokawa
Tatsuya Yamagishi
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20072764L publication Critical patent/NO20072764L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives forbindelser av formel (I): eller et farmasøytisk akseptabelt salt derav, hvor R1, R2, R3, R4, R5, R6, R7, R8, A og B er hver som beskrevet heri eller et farmasøytisk akseptabelt salt, og sammensetninger inneholdende slike forbindelser og fremgangsmåter for behandling og anvendelse, omfattende slike forbindelser for behandling av tilstander mediert av syrepumpeantagonistisk aktivitet, så som, men ikke begrenset til, gastrointestinal sykdom, gastroøsofagal sykdom, gastroøsofagal reflukssykdom (GERD), peptisk ulcer, gastrisk ulcer, duodenal ulcer, NSAID-induserte ulcere, gastritt, infeksjon av Helicobacter pylori, dyspepsi, funksjonell dyspepsi, Zollinger-Ellison syndrom, ikke-erosiv reflukssykdom (NERD), viseral smerte, hjertebrann, kvalme, øsofagitt, dysfagi, hypersalivering, luftveisforstyrrelser eller astma.
NO20072764A 2004-12-17 2007-05-31 Kromanderivater som er nyttige syrepumpeantagonister NO20072764L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63696304P 2004-12-17 2004-12-17
US69577205P 2005-06-29 2005-06-29
PCT/IB2005/003758 WO2006064339A1 (en) 2004-12-17 2005-12-07 Chromane derivatives useful as acid pump antagonists

Publications (1)

Publication Number Publication Date
NO20072764L true NO20072764L (no) 2007-07-03

Family

ID=35995811

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072764A NO20072764L (no) 2004-12-17 2007-05-31 Kromanderivater som er nyttige syrepumpeantagonister

Country Status (18)

Country Link
US (1) US20090291977A1 (no)
EP (1) EP1838309B1 (no)
JP (1) JP2008524199A (no)
KR (1) KR20070086294A (no)
AP (1) AP2007004023A0 (no)
AT (1) ATE405262T1 (no)
AU (1) AU2005315303A1 (no)
BR (1) BRPI0519598A2 (no)
CA (1) CA2591412A1 (no)
DE (1) DE602005009257D1 (no)
EA (1) EA011512B1 (no)
ES (1) ES2313444T3 (no)
IL (1) IL183602A0 (no)
MA (1) MA29095B1 (no)
MX (1) MX2007007010A (no)
NO (1) NO20072764L (no)
TN (1) TNSN07227A1 (no)
WO (1) WO2006064339A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007026218A2 (en) * 2005-09-01 2007-03-08 Pfizer Japan Inc. Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonists
WO2007107827A1 (en) * 2006-03-17 2007-09-27 Raqualia Pharma Inc. Chromane derivatives
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
CN106163527A (zh) 2013-11-22 2016-11-23 Cl生物科技有限责任公司 用于治疗和预防骨质疏松症的胃泌素拮抗剂
JP6315708B2 (ja) * 2015-06-22 2018-04-25 日本電信電話株式会社 リチウム空気二次電池、リチウム空気二次電池の製造方法及びリチウム空気二次電池を備えた装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
RS20050377A (en) * 2002-11-19 2007-11-15 Altana Pharma Ag., 8-substituted imidazopyridines

Also Published As

Publication number Publication date
EA011512B1 (ru) 2009-04-28
WO2006064339A1 (en) 2006-06-22
EP1838309A1 (en) 2007-10-03
ES2313444T3 (es) 2009-03-01
BRPI0519598A2 (pt) 2009-03-10
EP1838309B1 (en) 2008-08-20
DE602005009257D1 (de) 2008-10-02
US20090291977A1 (en) 2009-11-26
MA29095B1 (fr) 2007-12-03
ATE405262T1 (de) 2008-09-15
TNSN07227A1 (fr) 2008-11-21
MX2007007010A (es) 2007-07-10
IL183602A0 (en) 2007-09-20
CA2591412A1 (en) 2006-06-22
AU2005315303A1 (en) 2006-06-22
JP2008524199A (ja) 2008-07-10
AP2007004023A0 (en) 2007-06-30
EA200701087A1 (ru) 2008-02-28
KR20070086294A (ko) 2007-08-27

Similar Documents

Publication Publication Date Title
TW200732326A (en) Chromane substituted benzimidazole derivatives
ATE442140T1 (de) Chroman-substituierte benzimidazolderivate als säurepumpenantagonisten
ATE512969T1 (de) Benzimidazolderivate als selektive säurepumpenhemmer
CY1114415T1 (el) 1-ετεροκυκλυλσουλφονυλ, 2-αμινομεθυλ, 5-(ετερο-) αρυλ υποκατεστημενα 1-η-πυρρολιου παραγωγα ως αναστολεις εκκρισης οξεος
NZ591793A (en) Substituted 1-(4-fluoro-5-(2-fluoropyridin-3-yl)-1-((pyrindin-2-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine compounds
PL409463A1 (pl) Kryształy (R) lub (S)-2-[[[3-metylo-4(2,2,2-trifluoroetoksy)-2-pirydynylo] metylo] sulfinylo]-1H-benzimidazolu, kompozycja farmaceutyczna zawierająca te kryształy i ich zastosowanie oraz sposób ich stabilizacji
NO20072764L (no) Kromanderivater som er nyttige syrepumpeantagonister
EE04279B1 (et) Omeprasooli kristalne vorm
JP2006512316A5 (no)
NO20092464L (no) Faste former av rasemisk ilaprazol
NO20082758L (no)
EA200701529A1 (ru) Применение производных тетрамовой кислоты для борьбы с насекомыми из рода вшей растений стернорринха (sternorryncha)
CL2009000547A1 (es) Forma cristalina de (r)-2[[[3-metil-4-(2,2,2-trifluoroetoxi)-2-piridinil]metil]sulfinil]-1h-bencimidazol, metodo de preparacion; composicion farmaceutica y su uso para la profilaxis o tratamiento de ulcera peptica, gastritis, esofagitis erosiva, esofago de barret,dispepsia funcional, cancer gastrico.
NO20070089L (no) DPP-IV inhibitorer
DE60020967D1 (de) Kristalle von lansoprazole
JP2008535774A5 (no)
WO2010077101A3 (ko) 신규한 티아졸리딘디온 유도체 및 그의 용도
WO2011071927A3 (en) Treatments for gastrointestinal disorders
RU2007132704A (ru) Органические соединения
DE60314105D1 (de) Alkylammoniumsalze von omeprazol und esomeprazol
WO2007072142A3 (en) Benzimidazole-5-carboxamide derivatives
WO2007026218A3 (en) Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonists
RU2006141255A (ru) Соединение имидазопиридина
JP2008524199A5 (no)
UY30205A1 (es) Derivados de cromano, sales del mismo farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application